Prescribing Pattern for Covid 19 Positive Patients in Bangladesh

Abstract

Corona virus diseases 2019 commonly known as (Covid 19) caused by SARS-CoV-2, is a life threatening highly infectious severe acute respiratory syndrome. It has been associated with increased mortality all over the world. Many treatment guidelines had been adopted to cure or prevent Covid 19 infections. This study is conducted with a view to go through the scholarly articles to get an overall idea about the drugs used across the globe during the pandemic to manage covid infected patients. Most cases hospital admission was not required. However, from the literature review it is found that various types of drugs were administered including antiviral, antibiotics, antimalarial, vaccine, anti-coagulant drugs, anti- histamine. On the other side, based on the prescription survey it is noticed that ivermectin, moxifloxacin, levofloxacin, some steroid, tocilizumab, rivaroxaban were prescribed to reduce covid induced complications. But in the study, it remained unclear why Ivermectin alone or with other antibiotics were mostly given to the covid positive patients in the study area of Bangladesh whereas use of Ivermectin was limited in the other countries. Further research may be conducted to find out the plausible reasons behind this.